Advertisement

Topics

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

2010-07-15 17:00:00 | BioPortfolio

Summary

The COGENT-4 Field Following Study will evaluate the clinical performance of the Boston Scientific TELIGEN 100 HE Implantable Cardioverter Defibrillator (ICD), the COGNIS 100 HE Cardiac Resynchronization Therapy ICD (CRT-D) systems and the RELIANCE 4-SITE defibrillation lead (when available). An optional sub-study will also evaluate the clinical performance of the Reverse Mode Switch (RMS) feature in the TELIGEN 100 HE DR ICD.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Conditions

Ventricular Tachycardia, Ventricular Fibrillation

Intervention

Cognis 100-D, Teligen DR, VR 100 HE

Location

KAS Gentofte Hospital
Hellerup
Denmark
2900

Status

Completed

Source

Guidant Corporation

Results (where available)

View Results

Links

Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [1978 Associated Clinical Trials listed on BioPortfolio]

Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction

The BERLIN VT study is designed to evaluate the impact of prophylactic ventricular tachycardia (VT) ablation on all-cause mortality and unplanned hospital admission for congestive heart fa...

Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or ...

Termination Therapy for Ventricular Tachyarrhythmias

This observation study evaluates the safety and effectiveness of UPT therapy in subjects during either an indicated ventricular tachycardia ablation procedure or an ICD implant procedure.

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

The objective of this clinical investigation is to evaluate the safety and efficacy of the CyberHeart System in patients with refractory ventricular tachycardia (VT). The ablation will be...

Management of Supraventricular Tachycardia of Children

• Supraventricular tachycardia (SVT) is defined as an abnormally rapid heart rhythm originating above the ventricles. It usually has narrow complex tachycardia but this is not always the...

PubMed Articles [1966 Associated PubMed Articles listed on BioPortfolio]

Ablation Compared to Drug Therapy for Recurrent Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy; Results from a Multicenter Study.

The comparative efficacy of antiarrhythmic drug therapy (AAD) versus ventricular tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy (ARVC) is unknown.

Substrates and potential therapeutics of ventricular arrhythmias in heart failure.

Heart failure (HF) is a clinical syndrome characterized by ventricular contractile dysfunction. About 50% of death in patients with HF are due to fetal ventricular arrhythmias including ventricular ta...

Prognostic Significance of Non-Sustained Ventricular Tachycardia Depends on Its Rate and DurationNon-sustained ventricular tachycardia episodes predict future hospitalization in ICD recipients with heart failure.

Surviving Refractory Out-of-Hospital Ventricular Fibrillation Cardiac Arrest: Critical Care and Extracorporeal Membrane Oxygenation Management.

Resuscitation of refractory out-of-hospital ventricular fibrillation/ventricular tachycardia (VF/VT) cardiac arrest using extracorporeal membrane oxygenation (ECMO) establishes a complex patient popul...

Transient under-sensing of the ventricular lead during abdominal ultrasound as cause of ventricular fibrillation.

Pacemaker-induced arrhythmias represent a very rare complication. Algorithm-induced VT have been described but this report is the first to describe a ventricular fibrillation caused by transient under...

Medical and Biotech [MESH] Definitions

Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.

A potentially lethal cardiac arrhythmia characterized by an extremely rapid, hemodynamically unstable ventricular tachycardia (150-300 beats/min) with a large oscillating sine-wave appearance. If untreated, ventricular flutter typically progresses to VENTRICULAR FIBRILLATION.

A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.

Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia (TACHYCARDIA, VENTRICULAR) that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias (called synchronized defibrillation or CARDIOVERSION), using relatively low-level discharges synchronized to the patient's ECG waveform. (UMDNS, 2003)

An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

More From BioPortfolio on "Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial